Keel Point’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Keel Point's GILD Position: Q3 2026 in Review
Keel Point increased its Gilead Sciences (GILD) stake by 32% in Q3 2026, buying an estimated $322K and bringing the position to 9,364 shares worth $1.4M. The position accounts for 0.06% of the portfolio, ranked #168.
Keel Point first reported a position in GILD in Q4 2016 and has held it in 14 quarters since. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Keel Point held 9,364 shares of Gilead Sciences worth $1.4M as of Q3 2026.
- Keel Point bought 2,296 Gilead Sciences shares in Q3 2026, an estimated $322K.
- Gilead Sciences made up 0.06% of Keel Point's portfolio in Q3 2026, its #168 holding.
- Keel Point first reported a position in Gilead Sciences in Q4 2016 and has held it in 14 quarters since.
- 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Keel Point's 13F filing for Q3 2026, filed 16 Nov 2026.